NO20060109L - Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning - Google Patents

Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning

Info

Publication number
NO20060109L
NO20060109L NO20060109A NO20060109A NO20060109L NO 20060109 L NO20060109 L NO 20060109L NO 20060109 A NO20060109 A NO 20060109A NO 20060109 A NO20060109 A NO 20060109A NO 20060109 L NO20060109 L NO 20060109L
Authority
NO
Norway
Prior art keywords
alat
alpha
preparation
detergents
antitrypsin solution
Prior art date
Application number
NO20060109A
Other languages
English (en)
Inventor
Juergen Romisch
Petra Schulz
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20060109L publication Critical patent/NO20060109L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av AlAT fra AlAT-holdige løsninger, som omfatter følgende trinn: (a) underkastelse av en AlA.T-holdig løsning anionbytterkromatografi; (b) tilsetning av detergenter og eventuelt et løsningsmiddel for inaktivering av virus med lipidkappe; (c) etterfiilgt av økning av saltkonsentrasjonen for utsalting av detergentene. AlAT har en renhet på >90% med en aktivitet på >0,8 PEU/mg i dets aktive form.
NO20060109A 2003-08-12 2006-01-06 Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning NO20060109L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
NO20060109L true NO20060109L (no) 2006-02-15

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060109A NO20060109L (no) 2003-08-12 2006-01-06 Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning

Country Status (22)

Country Link
US (1) US20060194300A1 (no)
EP (1) EP1654284B1 (no)
JP (1) JP4668904B2 (no)
KR (1) KR20060070543A (no)
CN (1) CN1867582B (no)
AT (1) ATE428730T1 (no)
AU (1) AU2004262578B2 (no)
BR (1) BRPI0412835A (no)
CA (1) CA2534900A1 (no)
DE (1) DE602004020632D1 (no)
DK (1) DK1654284T3 (no)
ES (1) ES2324168T3 (no)
IL (1) IL172868A0 (no)
NO (1) NO20060109L (no)
PL (1) PL1654284T3 (no)
PT (1) PT1654284E (no)
RS (1) RS20060077A (no)
RU (1) RU2370500C2 (no)
SI (1) SI1654284T1 (no)
UA (1) UA86775C2 (no)
WO (1) WO2005014648A1 (no)
ZA (1) ZA200601206B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027821A2 (en) * 2003-09-22 2005-03-31 Kamada Ltd. Large scale preparation of alpha-1 proteinase inhibitor and use thereof
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
CN100562523C (zh) * 2006-07-26 2009-11-25 河北大安制药有限公司 α1-抗胰蛋白酶的制备方法
HUE030205T2 (en) * 2007-11-02 2017-05-29 Grifols Therapeutics Inc A method, composition, and product for providing alpha-1-antitrypsin
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
WO2016207353A1 (en) * 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
CA3012694A1 (en) * 2016-02-03 2017-08-10 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
EP0288841B1 (en) * 1987-04-27 1992-12-30 Miles Inc. Method of preparing highly purified alpha-1-proteinase inhibitor
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
WO1997009350A1 (en) * 1995-09-07 1997-03-13 Ppl Therapeutics (Scotland) Ltd. Purification of alpha-1 proteinase inhibitor
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
JP2007523883A (ja) 2007-08-23
CN1867582A (zh) 2006-11-22
US20060194300A1 (en) 2006-08-31
UA86775C2 (ru) 2009-05-25
AU2004262578B2 (en) 2010-05-06
ES2324168T3 (es) 2009-07-31
EP1654284B1 (en) 2009-04-15
CN1867582B (zh) 2010-06-16
PT1654284E (pt) 2009-07-06
EP1654284A1 (en) 2006-05-10
IL172868A0 (en) 2006-06-11
CA2534900A1 (en) 2005-02-17
BRPI0412835A (pt) 2006-09-26
ZA200601206B (en) 2007-05-30
PL1654284T3 (pl) 2009-09-30
DK1654284T3 (da) 2009-07-20
SI1654284T1 (sl) 2009-10-31
DE602004020632D1 (de) 2009-05-28
ATE428730T1 (de) 2009-05-15
RS20060077A (sr) 2008-08-07
JP4668904B2 (ja) 2011-04-13
RU2370500C2 (ru) 2009-10-20
AU2004262578A1 (en) 2005-02-17
RU2006107533A (ru) 2006-07-27
WO2005014648A1 (en) 2005-02-17
KR20060070543A (ko) 2006-06-23

Similar Documents

Publication Publication Date Title
NO20060109L (no) Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning
Kim et al. Reaction catalyzed by GenK, a cobalamin-dependent radical S-adenosyl-L-methionine methyltransferase in the biosynthetic pathway of gentamicin, proceeds with retention of configuration
ECSP077317A (es) Procedimiento para producir derivados de amina opticamente activos
UA109774C2 (uk) Кристалічні форми саксагліптину та процес його одержання (варіанти)
NO20052071L (no) Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer.
NO973035L (no) Hydroksaminsyre-holdige inhibitorer for matriks-metallproteaser
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
BRPI0520252A2 (pt) método de desacilar sucralose-6-éster
ATE208765T1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
Aman et al. From adenosine to 3 ‘-deoxyadenosine: development and scale up
CN106256830B (zh) 一种氘代的ido抑制剂及其制备方法和用途
NZ510748A (en) Crystal of diuridine tetraphosphate or salt thereof
Grossi et al. Decomposition of S-nitrosothiols: Unimolecular versus autocatalytic mechanism
FR2866890B1 (fr) Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
AR035808A1 (es) Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
IT1311984B1 (it) Procedimento per la preparzione di gabapentin.
MXPA05008842A (es) Proceso quimico.
DK1280812T3 (da) Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme
DE602004032024D1 (de) Behandlung hochleistungsfähiger pigmentfarbstoffe mit dispergierenden etheramin-salzen
AR002510A1 (es) Un procedimiento para la preparacion de derivados de 1-(3-trialquilsilil- fenil)-2,2,2-trifluorometiletanona que son utiles en el tratamiento de laenfermedad de alzheimer y demencia senil y procedimiento para la purificacion de dicho derivado con dicho procedimiento de preparacion.
Gallati et al. Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
JPH0374347A (ja) シス・トランス混合菊酸の光学分割法
Chander et al. Modified synthesis of deoxyadenosine-5'-(35 S)-thiomonophosphate [dAMP (35 S)] with high specific activity: An important starting material for the synthesis of deoxyadenosine-5'-(&;# 945;-35 S)-thiotriphosphate [dATP (&;# 945;-35 S)]
ITMI913375A1 (it) Procedimento per la produzione di neuraminidasi
DE60123046D1 (de) Ein lösungsmittelaustauschverfahren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application